Isolation of PBMCs and generation of EBV-transformed cell lines

YT Yukiko Takeda
MU Masahiro Ueki
JM Junpei Matsuhiro
EW Erik Walinda
TT Takayuki Tanaka
MY Masafumi Yamada
HF Hiroaki Fujita
ST Shunichiro Takezaki
IK Ichiro Kobayashi
ST Sakura Tamaki
SN Sanae Nagata
NM Noriko Miyake
NM Naomichi Matsumoto
MO Mitsujiro Osawa
TY Takahiro Yasumi
TH Toshio Heike
FO Fumiaki Ohtake
MS Megumu K. Saito
JT Junya Toguchida
JT Junko Takita
TA Tadashi Ariga
KI Kazuhiro Iwai
request Request a Protocol
ask Ask a question
Favorite

PBMCs were separated from heparinized peripheral blood samples obtained from a healthy control and the patient by density gradient centrifugation using Histo Paque 1077 (Sigma-Aldrich). EBV-transformed cell lines (EBV-LCLs) were generated by in vitro transformation of human B cells with EBV (Stain B95-8) as described previously (Yamada et al., 2012). EBV-B cells were grown in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin. To generate monocyte-derived macrophages (MDMs), CD14-positive cells were sorted using CD14 microbeads (Miltenyi Biotec), suspended in RPMI supplemented with 10% FBS, penicillin/streptomycin, and 5 ng/ml G-CSF, plated (1 × 105 cells per well) into 96-well plates, and incubated for 7 days.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A